These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22886115)

  • 1. A clinicopathologic study of Ki-67 proliferation index in colorectal carcinoma.
    Ahmed NY; Ismail AT; Kareem TS
    Saudi Med J; 2012 Aug; 33(8):841-5. PubMed ID: 22886115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
    Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
    Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
    Oshima CT; Iriya K; Forones NM
    Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
    Nabi U; Nagi AH; Sami W
    J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Ki 67 proliferative index with clinical and pathological features on tissue sections of non Hodgkins lymphoma by immunostaining.
    Naz E; Mirza T; Aziz S; Ali A; Danish F
    J Pak Med Assoc; 2011 Aug; 61(8):748-52. PubMed ID: 22355994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma.
    Valera V; Yokoyama N; Walter B; Okamoto H; Suda T; Hatakeyama K
    Br J Surg; 2005 Aug; 92(8):1002-7. PubMed ID: 15931661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression in colorectal carcinoma in relation to histopathological features in Ugandan patients.
    Rambau PF; Odida M; Wabinga H
    Afr Health Sci; 2008 Dec; 8(4):234-8. PubMed ID: 20589130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer].
    de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G
    G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical distribution of p53 and Ki-67 in 2 cases of colorectal carcinoma occurring in ulcerative colitis].
    Maruyama K; Saigusa N; Baba S; Kino I
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():145-8. PubMed ID: 7611778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of clinicopathological characteristics between colorectal signet-ring cell carcinoma and mucinous adenocarcinoma].
    Liu Q; Wang CF; Zhao DB; Gao JD; Bai XF; Xie YB
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(44):3124-6. PubMed ID: 21211342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma.
    Kim MJ; Gu MJ; Chang HK; Yu E
    Histopathology; 2015 Mar; 66(4):508-16. PubMed ID: 25400081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of polo like kinase1 and Ki-67 in gastric carcinoma].
    Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):801-2. PubMed ID: 16545190
    [No Abstract]   [Full Text] [Related]  

  • 19. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
    Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V
    Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.